U.S. Markets closed

AcelRx Pharmaceuticals, Inc. (ACRX)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.100+0.05 (+2.44%)
At close: 4:00PM EDT

2.100 0.05 (2.44%)
After hours: 4:57PM EDT

People also watch
ALIMECYTAVEOAEGRINFI
Full screen
Previous Close2.050
Open2.100
Bid2.050 x 18800
Ask2.100 x 13600
Day's Range2.000 - 2.117
52 Week Range1.950 - 4.080
Volume365,311
Avg. Volume362,851
Market Cap95.3M
Beta2.91
PE Ratio (TTM)-1.99
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube15 days ago

    ETFs with exposure to AcelRx Pharmaceuticals, Inc. : June 13, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to AcelRx Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to ACRX-US. Comparing the performance and risk of AcelRx Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube2 months ago

    ETFs with exposure to AcelRx Pharmaceuticals, Inc. : May 11, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to AcelRx Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to ACRX-US. Comparing the performance and risk of AcelRx Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • AcelRx Pharmaceuticals, Inc. :ACRX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017
    Capital Cube2 months ago

    AcelRx Pharmaceuticals, Inc. :ACRX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017

    Categories: Yahoo FinanceGet free summary analysis AcelRx Pharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of AcelRx Pharmaceuticals, Inc. – Pain Therapeutics, Inc., Insys Therapeutics, Inc., Medicines Company and Cara Therapeutics Inc (PTIE-US, INSY-US, MDCO-US and CARA-US) that have also reported for this period. ... Read more (Read more...)